- Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
-
Reinson T, Buchanan RM, Byrne CD
- KMID: 2539798
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S157-S170.
- doi: 10.3350/cmh.2022.0348
In the last 20 years, noninvasive serum biomarkers to identify liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) have been developed, validated against liver biopsy (the gold standard... -
- CITED
-
- Close
- SHARE
-
- Close
